/KASE, December 17, 2025/ – Kazakhstan Stock Exchange (KASE) announces that from December 18, 2025, KASE will suspend trading of the following common shares in repo operations in trading modes with participation of the central counterparty:

1) US00206R1023 (KASE Global sector, T_KZ) of AT&T Inc. (USA), which settlement date falls on January 12, 2026, and subsequent dates; the trading will resume on January 14, 2026;

2) US0028241000 (KASE Global sector, ABT_KZ) of Abbott Lab. (USA), which settlement date falls on January 15, 2026, and subsequent dates; the trading will resume on January 19, 2026;

3) US7170811035 (KASE Global sector, PFE_KZ) of Pfizer Inc. (USA), which settlement date falls on January 23, 2026, and subsequent dates; the trading will resume on January 26, 2026.

Trading is suspended in accordance with subparagraph 12) of paragraph 1 of Article 13 of the KASE's internal document "Rules of exchange activities" due to KASE having the information on closing of the register for payment of dividends on the specified common shares.

[2025-12-17]